Spits H, et al. Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145–9.

PubMed  Google Scholar 

Gasteiger G, et al. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science. 2015;350(6263):981–5.

PubMed  PubMed Central  Google Scholar 

Vivier E, et al. Natural killer cell therapies. Nature. 2024;626(8000):727–36.

PubMed  Google Scholar 

Torcellan T, et al. Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection. Immunity. 2024;57(1):124–140 e7.

Laskowski TJ, Biederstadt A, Rezvani K. Natural killer cells in antitumour adoptive cell immunotherapy. Nat Rev Cancer. 2022;22(10):557–75.

PubMed  PubMed Central  Google Scholar 

Weizman OE, et al. ILC1 confer early host protection at initial sites of viral infection. Cell. 2017;171(4):795–808.e12.

PubMed  PubMed Central  Google Scholar 

Corral D, et al. ILC precursors differentiate into metabolically distinct ILC1-like cells during Mycobacterium tuberculosis infection. Cell Rep. 2022;39(3):110715.

Jowett GM, et al. ILC1 drive intestinal epithelial and matrix remodelling. Nat Mater. 2021;20(2):250–9.

PubMed  Google Scholar 

Cortez VS, et al. Transforming growth factor-beta signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity. 2016;44(5):1127–39.

PubMed  PubMed Central  Google Scholar 

Peng H, et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest. 2013;123(4):1444–56.

PubMed  PubMed Central  Google Scholar 

Bai L, et al. Liver type 1 innate lymphoid cells develop locally via an interferon-gamma-dependent loop. Sci. 2021;371(6536):eaba4177.

Gordon SM, et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity. 2012;36(1):55–67.

PubMed  PubMed Central  Google Scholar 

Daussy C, et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med. 2014;211(3):563–77.

PubMed  PubMed Central  Google Scholar 

Mackay LK, et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science. 2016;352(6284):459–63.

PubMed  Google Scholar 

He J, et al. Prdm1 positively regulates liver group 1 ILCs cancer immune surveillance and preserves functional heterogeneity. Elife. 2024;13:RP92948.

Fuchs A, et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity. 2013;38(4):769–81.

PubMed  PubMed Central  Google Scholar 

Jaeger N, et al. Diversity of group 1 innate lymphoid cells in human tissues. Nat Immunol. 2024;25(8):1460–73.

PubMed  Google Scholar 

Zhang J, et al. T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1. Eur J Immunol. 2018;48(5):738–50.

PubMed  Google Scholar 

Cuff AO, et al. Eomeshi NK cells in human liver are long-lived and do not recirculate but can be replenished from the circulation. J Immunol. 2016;197(11):4283–91.

PubMed  PubMed Central  Google Scholar 

Harmon C, et al. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver. Eur J Immunol. 2016;46(9):2111–20.

PubMed  Google Scholar 

Rumgay H, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598–606.

PubMed  PubMed Central  Google Scholar 

Xue JS, et al. The prognostic value of natural killer cells and their receptors/ligands in hepatocellular carcinoma: a systematic review and meta-analysis. Front Immunol. 2022;13: 872353.

PubMed  PubMed Central  Google Scholar 

Wei H, et al, AKR1D1 suppresses liver cancer progression by promoting bile acid metabolism-mediated NK cell cytotoxicity. Cell Metab. 2025;37(5):1103–1118 e7.

Gao Y, et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol. 2017;18(9):1004–15.

PubMed  Google Scholar 

Ducimetiere L, et al. Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc Natl Acad Sci USA. 2021;118(27):e2026271118.

Kansler ER, et al. Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies. Nat Immunol. 2022;23(6):904–15.

PubMed  PubMed Central  Google Scholar 

Nixon BG, et al. Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity. Sci Immunol. 2022;7(70):eabi8642.

Yan J, et al. GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity. Nat Immunol. 2024;25(11):2057–67.

PubMed  Google Scholar 

Tang F, et al. mRNA-seq whole-transcriptome analysis of a single cell. Nat Methods. 2009;6(5):377–82.

PubMed  Google Scholar 

Tang F, et al. A pan-cancer single-cell panorama of human natural killer cells. Cell. 2023;186(19):4235–4251 e20.

Dufva O, et al. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers. Immunity. 2023;56(12):2816–2835 e13.

Jia G, et al. Spatial immune scoring system predicts hepatocellular carcinoma recurrence. Nature. 2025;640(8060):1031–41.

PubMed  Google Scholar 

Ramachandran P, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512–8.

PubMed  PubMed Central  Google Scholar 

Zhao J, et al. Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human. Cell Discov. 2020;6:22.

PubMed  PubMed Central  Google Scholar 

Andrews TS, et al. Single-cell, single-nucleus, and spatial RNA sequencing of the human liver identifies cholangiocyte and mesenchymal heterogeneity. Hepatol Commun. 2022;6(4):821–40.

PubMed  Google Scholar 

Sharma A, et al. Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma. Cell. 2020;183(2):377–394 e21.

Ma L, et al. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer. Nat Commun. 2022;13(1):7533.

PubMed  PubMed Central  Google Scholar 

Lu Y, et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun. 2022;13(1):4594.

PubMed  PubMed Central  Google Scholar 

Xiong X, et al. Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis. Mol Cell. 2019;75(3):644–660 e5.

Wong P, et al. T-BET and EOMES sustain mature human NK cell identity and antitumor function. J Clin Invest. 2023;133(13):e162530.

Wagner JA, et al. Stage-specific requirement for Eomes in mature NK cell homeostasis and cytotoxicity. Cell Rep. 2020;31(9):107720.

Tang Z, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–60.

PubMed  PubMed Central  Google Scholar 

Sinha D, et al. dropClust: efficient clustering of ultra-large scRNA-seq data. Nucleic Acids Res. 2018;46(6):e36.

PubMed  PubMed Central  Google Scholar 

Seillet C, Belz GT, Huntington ND. Development, homeostasis, and heterogeneity of NK cells and ILC1. Curr Top Microbiol Immunol. 2016;395:37–61.

PubMed  Google Scholar 

Robinette ML, et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol. 2015;16(3):306–17.

PubMed  PubMed Central  Google Scholar 

Cuff AO, Male V. Conventional NK cells and ILC1 are partially ablated in the livers of Ncr1 (iCre)Tbx21 (fl/fl) mice. Wellcome Open Res. 2017;2: 39.

PubMed  PubMed Central  Google Scholar 

Kiekens L, et al. T-BET and EOMES accelerate and enhance functional differentiation of human natural killer cells. Front Immunol. 2021;12: 732511.

PubMed  PubMed Central  Google Scholar 

Lee EHC, Wong DCP, Ding JL. NK cells in a tug-of-war with cancer: the roles of transcription factors and cytoskeleton. Front Immunol. 2021;12: 734551.

PubMed  PubMed Central  Google Scholar 

Delconte RB, et al. The helix-loop-helix protein ID2 governs NK cell fate by tuning their sensitivity to interleukin-15. Immunity. 2016;44(1):103–15.

PubMed  Google Scholar 

Miyagi T, et al. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J Exp Med. 2007;204(10):2383–96.

PubMed  PubMed Central  Google Scholar 

Schmied L, et al. SHP-1 localization to the activating immune synapse promotes NK cell tolerance in MHC class I deficiency. Sci Signal. 2023;16(780):eabq0752.

Rafei H, et al. CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells. Nature. 2025;643(8073):1076–1086.

Yang R, et al. Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria. Cell. 2020;183(7):1826–1847 e31.